Group One Trading’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MLTX
Group One Trading's MLTX Position: Q3 2026 in Review
Group One Trading sold out of MoonLake Immunotherapeutics (MLTX) in Q3 2026, closing a stake of 3,179 shares — an estimated $52K sold.
Group One Trading first reported a position in MLTX in Q3 2023 and held it in 7 quarters. The position peaked at $679K in Q1 2024. 169 funds tracked by Wall St. Rank hold MLTX as of Q3 2026.
- Group One Trading reported no remaining MoonLake Immunotherapeutics position as of Q3 2026 after selling out during the quarter.
- Group One Trading sold 3,179 MoonLake Immunotherapeutics shares in Q3 2026, an estimated $52K.
- Group One Trading first reported a position in MoonLake Immunotherapeutics in Q3 2023 and held it in 7 quarters.
- Group One Trading's MoonLake Immunotherapeutics position peaked at $679K in Q1 2024.
- 169 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.